Viral Vector Characterisation

Viral vector characterisation comprehensively assesses manufacturing viral vehicles for gene therapy. Infectivity titre quantitates functional viral particles. Particle-to-infectivity ratio indicates manufacturing efficiency. Genetic stability assessment confirms insert integrity. Purity assessment detects host cell contaminants.

Regulatory submissions include extensive characterisation. Quality control monitoring verifies consistency. Manufacturing modifications require re-characterisation. Post-approval surveillance confirms stability. Emerging assays improve characterisation capability.